Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Molecular & Cellular Proteomics : MCP
|
April 13, 2010
Plasma membrane proteomics and its application in clinical cancer biomarker discovery
Rikke Leth-Larsen, Rikke R Lund, Henrik J Ditzel
Journal of Proteome Research
|
April 4, 2009
Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers
Rikke Lund, Rikke Leth-Larsen, Ole N Jensen, et al.
Danish Medical Journal
|
April 6, 2018
Research integrity among PhD students within clinical research at the University of Southern Denmark
Lone Bredahl Jensen, Kirsten Ohm Kyvik, Rikke Leth-Larsen, et al.
Immunobiology
|
April 7, 2007
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
Rikke Leth-Larsen, Fei Zhong, Vincent T K Chow, et al.
Cancer Genomics & Proteomics
|
September 20, 2012
Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics
Mikkel G Terp, Rikke R Lund, Ole N Jensen, et al.
International Journal of Cancer
|
April 28, 2015
S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype
Sidse Ehmsen, Lea Tykgaard Hansen, Martin Bak, et al.
Nature Protocols
|
December 4, 2010
Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry
Giuseppe Palmisano, Sara Eun Lendal, Kasper Engholm-Keller, et al.
Oncoimmunology
|
June 23, 2017
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
Martin H Pedersen, Brian L Hood, Hans Christian Beck, et al.
Proteomics
|
May 25, 2012
Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins
Rikke Raaen Lund, Mikkel Green Terp, Anne-Vibeke Laenkholm, et al.
Clinical Immunology (Orlando, Fla.)
|
July 17, 2003
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia
Rikke Leth-Larsen, Claudia Nordenbaek, Ida Tornoe, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Molecular & Cellular Proteomics : MCP
|
April 13, 2010
Plasma membrane proteomics and its application in clinical cancer biomarker discovery
Rikke Leth-Larsen, Rikke R Lund, Henrik J Ditzel
Journal of Proteome Research
|
April 4, 2009
Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers
Rikke Lund, Rikke Leth-Larsen, Ole N Jensen, et al.
Danish Medical Journal
|
April 6, 2018
Research integrity among PhD students within clinical research at the University of Southern Denmark
Lone Bredahl Jensen, Kirsten Ohm Kyvik, Rikke Leth-Larsen, et al.
Immunobiology
|
April 7, 2007
The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages
Rikke Leth-Larsen, Fei Zhong, Vincent T K Chow, et al.
Cancer Genomics & Proteomics
|
September 20, 2012
Identification of markers associated with highly aggressive metastatic phenotypes using quantitative comparative proteomics
Mikkel G Terp, Rikke R Lund, Ole N Jensen, et al.
International Journal of Cancer
|
April 28, 2015
S100A14 is a novel independent prognostic biomarker in the triple-negative breast cancer subtype
Sidse Ehmsen, Lea Tykgaard Hansen, Martin Bak, et al.
Nature Protocols
|
December 4, 2010
Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry
Giuseppe Palmisano, Sara Eun Lendal, Kasper Engholm-Keller, et al.
Oncoimmunology
|
June 23, 2017
Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
Martin H Pedersen, Brian L Hood, Hans Christian Beck, et al.
Proteomics
|
May 25, 2012
Quantitative proteomics of primary tumors with varying metastatic capabilities using stable isotope-labeled proteins of multiple histogenic origins
Rikke Raaen Lund, Mikkel Green Terp, Anne-Vibeke Laenkholm, et al.
Clinical Immunology (Orlando, Fla.)
|
July 17, 2003
Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia
Rikke Leth-Larsen, Claudia Nordenbaek, Ida Tornoe, et al.
Page
of 3